Integrin-mediated cell adhesion (WP1185)
Canis familiaris
Integrins are receptors that mediate attachment between a cell and the tissues surrounding it, which may be other cells or the extracellular matrix (ECM). They also play a role in cell signaling and thereby define cellular shape, mobility, and regulate the cell cycle. Source: [[wikipedia:Integrins|Wikipedia]]
Authors
Thomas Kelder and Daniela DiglesCited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organism
Canis familiarisCommunities
Annotations
Pathway Ontology: integrin mediated signaling pathway
Participants
Label | Type | Compact Identifier | Comment |
---|---|---|---|
CDC42 | GeneProduct | ncbigene:607535 | CDC42; cell division cycle 42 (GTP binding protein 25kD) |
SHC1 | GeneProduct | ncbigene:490439 | SHC1; SHC (Src homology 2 domain containing) transforming protein 1 |
LOC476352 | GeneProduct | ncbigene:476352 | SHC3; neuronal Sh |
ARAF | GeneProduct | ncbigene:491857 | ARAF1; v-raf murine sarcoma 3611 viral oncogene homolog 1 [EC:2.7.1.-] |
BRAF | GeneProduct | ncbigene:475526 | BRAF; v-raf murine sarcoma viral oncogene homolog B1 [EC:2.7.1.-] |
RAF1 | GeneProduct | ncbigene:484648 | RAF1; v-raf-1 murine leukemia viral oncogene homolog 1 [EC:2.7.1.-] |
MAPK4 | GeneProduct | ncbigene:491690 | MAPK4; mitogen-activated protein kinase 4 [EC:2.7.1.-] |
MAPK7 | GeneProduct | ncbigene:489532 | MAPK7; mitogen-activated protein kinase 7 [EC:2.7.1.- |
CAPNS1 | GeneProduct | ncbigene:611746 | CAPNS1; calpain small subunit 1 [EC:3.4.22.17] |
MYLK2 | GeneProduct | ncbigene:477187 | MYLK2; myosin light chain kinase 2 skeletal muscle [EC:2.7.1.117 |
ARHGEF7 | GeneProduct | ncbigene:485552 | ARHGEF7; Rho guanine nucleotide exchange factor (GEF) 7 |
RAC1 | GeneProduct | ncbigene:403955 | RAC1; ras-related C3 botulinum toxin substrate 1 (rho family small GTP binding protein Rac1) |
RAC2 | GeneProduct | ncbigene:481271 | RAC2; ras-related C3 botulinum toxin substrate 2 (rho family small GTP binding protein Rac2) |
PDPK1 | GeneProduct | ncbigene:479875 | PDPK1; 3-phosphoinositide dependent protein kinase-1 [EC:2.7.1.37] |
VAV2 | GeneProduct | ncbigene:608060 | VAV2; vav 2 oncogene |
VAV3 | GeneProduct | ncbigene:479921 | VAV3; vav 3 oncogene |
ROCK2 | GeneProduct | ncbigene:482970 | ROCK2; Rho-associated coiled-coil containing protein kinase |
ROCK1 | GeneProduct | ncbigene:480181 | ROCK1; Rho-associated coiled-coil containing protein kinase |
SOS1 | GeneProduct | ncbigene:483042 | SOS1; son of sevenless homolog 1 (Drosophila) |
GIT2 | GeneProduct | ncbigene:477520 | GIT2; G protein-coupled receptor kinase-interactor 2 |
PIK3R2 | GeneProduct | ncbigene:609956 | PIK3R2; phosphoinositide-3-kinase regulatory subunit polypeptide 2 (p85 beta) |
ZYX | GeneProduct | ncbigene:482736 | ZYX; zyxin |
CAV1 | GeneProduct | ncbigene:403980 | CAV1; caveolin 1 caveolae protein 22kD |
CAV2 | GeneProduct | ncbigene:475294 | CAV2; caveolin 2 |
CAV3 | GeneProduct | ncbigene:484671 | CAV3; caveolin 3 |
FYN | GeneProduct | ncbigene:475032 | FYN; FYN oncogene related to SRC FGR YES [EC:2.7.1.112] |
GRB2 | GeneProduct | ncbigene:483312 | GRB2; growth factor receptor-bound protein 2 |
SEPP1 | GeneProduct | ncbigene:479346 | SEPP1; selenoprotein P plasma |
PTK2 | GeneProduct | ncbigene:475108 | PTK2; PTK2 protein tyrosine kinase 2 [EC:2.7.1.112 |
PTK2 | GeneProduct | ncbigene:475108 | PTK2; PTK2 protein tyrosine kinase 2 [EC:2.7.1.112 |
RHO | GeneProduct | ncbigene:493763 | RHO; rhodopsin (opsin 2 rod pigment) (retinitis pigmentosa 4 autosomal dominant) |
CSK | GeneProduct | ncbigene:487649 | CSK; c-src tyrosine kinase [EC:2.7.1.112] |
BCAR1 | GeneProduct | ncbigene:479648 | BCAR1; breast cancer anti-estrogen resistance 1 |
SRC | GeneProduct | ncbigene:485864 | SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) [EC:2.7.1.112] |
AKT1 | GeneProduct | ncbigene:490878 | AKT1; v-akt murine thymoma viral oncogene homolog 1 [EC:2.7.1.-] |
AKT2 | GeneProduct | ncbigene:449021 | AKT2; v-akt murine thymoma viral oncogene homolog 2 [EC:2.7.1.-] |
CAPN2 | GeneProduct | ncbigene:480118 | CAPN2; calpain 2 (m/II) large subunit [EC:3.4.22.17] |
CAPN3 | GeneProduct | ncbigene:487518 | CAPN3; calpain 3 (p94) [EC:3.4.22.17] |
CAPN5 | GeneProduct | ncbigene:485175 | CAPN5; calpain |
CAPN7 | GeneProduct | ncbigene:477062 | CAPN7; calpain 7 [EC:3.4.22.17 |
CAPN9 | GeneProduct | ncbigene:608044 | CAPN9; calpain 9 (nCL-4) [EC:3.4.22.17 |
CAPN10 | GeneProduct | ncbigene:607311 | CAPN10; calpain 10 [EC:3.4.22.17 |
CAPN11 | GeneProduct | ncbigene:609624 | CAPN11; calpain 11 [EC:3.4.22.17] |
CAPN6 | GeneProduct | ncbigene:492068 | CAPN6; calpain 6 [EC:3.4.22.17] |
PAK2 | GeneProduct | ncbigene:612814 | PAK2; p21 (CDKN1A)-activated kinase 2 [EC:2.7.1.-] |
PAK3 | GeneProduct | ncbigene:492067 | PAK3; p21 (CDKN1A)-activated kinase 3 [EC:2.7.1.-] |
PAK4 | GeneProduct | ncbigene:484513 | PAK4; p21(CDKN1A)-activated kinase 4 [EC:2.7.1.-] |
PAK6 | GeneProduct | ncbigene:487490 | PAK6; p21(CDKN1A)-activated kinase |
TLN1 | GeneProduct | ncbigene:474759 | TLN1; talin 1 |
MAP2K3 | GeneProduct | ncbigene:489547 | MAP2K3; mitogen-activated protein kinase kinase 3 [EC:2.7.1.-] |
MAP2K6 | GeneProduct | ncbigene:480454 | MAP2K6; mitogen-activated protein kinase kinase 6 [EC:2.7.1.- |
MAPK12 | GeneProduct | ncbigene:607023 | MAPK12; mitogen-activated protein kinase 12 [EC:2.7.1.-] |
AKT3 | GeneProduct | ncbigene:442964 | AKT3; v-akt murine thymoma viral oncogene homolog 3 (protein kinase B gamma) [EC:2.7.1.-] |
DOCK1 | GeneProduct | ncbigene:486934 | DOCK1; dedicator of cyto-kinesis |
RAPGEF1 | GeneProduct | ncbigene:491286 | GRF2; guanine nucleotide-releasing factor 2 (specific for crk proto-oncogene |
RAP1A | GeneProduct | ncbigene:483225 | RAP1A; RAP1A member of RAS oncogene family |
RAP1B | GeneProduct | ncbigene:608981 | RAP1B; RAP1B member of RAS oncogene family |
MAPK1 | GeneProduct | ncbigene:477575 | MAPK1; mitogen-activated protein kinase 1 [EC:2.7.1.-] |
MAPK6 | GeneProduct | ncbigene:478311 | MAPK6; mitogen-activated protein kinase 6 [EC:2.7.1.-] |
MAP2K1 | GeneProduct | ncbigene:478347 | MAP2K1; mitogen-activated protein kinase kinase 1 [EC:2.7.1.-] |
MAP2K2 | GeneProduct | ncbigene:611939 | MAP2K2; mitogen-activated protein kinase kinase 2 [EC:2.7.1.-] |
CAPN1 | GeneProduct | ncbigene:483745 | CAPN1; calpain 1 (mu/I) large subunit [EC:3.4.22.17] |
ITGA2 | GeneProduct | ncbigene:489208 | |
ITGA4 | GeneProduct | ncbigene:488429 | |
ITGA5 | GeneProduct | ncbigene:486493 | |
ITGA6 | GeneProduct | ncbigene:478800 | |
ITGA8 | GeneProduct | ncbigene:487119 | |
ITGA9 | GeneProduct | ncbigene:477021 | |
ITGA10 | GeneProduct | ncbigene:608287 | |
ITGA11 | GeneProduct | ncbigene:478353 | |
ITGA2B | GeneProduct | ncbigene:403789 | |
ITGAE | GeneProduct | ncbigene:480659 | |
ITGAD | GeneProduct | ncbigene:607096 | |
ITGAL | GeneProduct | ncbigene:489905 | |
ITGAM | GeneProduct | ncbigene:489928 | |
ITGAV | GeneProduct | ncbigene:488437 | |
ITGAX | GeneProduct | ncbigene:489929 | |
ITGB1 | GeneProduct | ncbigene:477956 | |
ITGB2 | GeneProduct | ncbigene:403770 | |
ITGB3 | GeneProduct | ncbigene:403788 | |
ITGB4 | GeneProduct | ncbigene:483318 | |
ITGB5 | GeneProduct | ncbigene:608977 | |
ITGB6 | GeneProduct | ncbigene:488368 | |
ITGB7 | GeneProduct | ncbigene:477598 | |
ITGB8 | GeneProduct | ncbigene:475253 | |
SRC | GeneProduct | ncbigene:485864 | SRC; v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) [EC:2.7.1.112] |
TNS1 | GeneProduct | ncbigene:488519 | TNS; tensi |
MAPK10 | GeneProduct | ncbigene:478464 | |
PXN | GeneProduct | ncbigene:486299 | PXN; paxillin |
ILK | GeneProduct | ncbigene:476836 | ILK; integrin-linked kinase [EC:2.7.1.-] |
PAK1 | GeneProduct | ncbigene:607885 | PAK1; p21/Cdc42/Rac1-activated kinase 1 (STE20 homolog yeast) [EC:2.7.1.-] |
VASP | GeneProduct | ncbigene:403936 | VASP; vasodilator-stimulated phosphoprotein |
ITGA7 | GeneProduct | ncbigene:481097 | |
ITGA1 | GeneProduct | ncbigene:489210 |
References
- Assembly and signaling of adhesion complexes. Sepulveda JL, Gkretsi V, Wu C. Curr Top Dev Biol. 2005;68:183–225. PubMed Europe PMC Scholia